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Pituitary adenylate cyclase activating polypetide (PACAP) constitutes a neuropeptide that is widely distributed in the host exert-
ing essential cytoprotective properties, whereas PACAP−/− mice display increased susceptibility to distinct immunopathological 
conditions. The orchestrated interplay between the gut microbiota and the host is pivotal in immune homeostasis and resistance to 
disease. Potential pertubations of the intestinal microbiota in PACAP−/− mice, however, have not been addressed so far. For the 
first time, we performed a comprehensive survey of the intestinal microbiota composition in PACAP−/− and wildtype (WT) mice 
starting 2 weeks postpartum until 18 months of age applying quantitative culture-independent techniques. Fecal enterobacteria 
and enterococci were lower in PACAP−/− than WT mice aged 1 month and ≥6 months, respectively. Whereas Mouse Intestinal 
Bacteroides were slightly higher in PACAP−/− versus WT mice aged 1 and 6 months, this later in life held true for Bacteroides/
Prevotella spp. (≥12 months) and lactobacilli (>15 months of age). Strikingly, health-beneficial bifidobacteria were virtually ab-
sent in the intestines of PACAP−/− mice, even when still breastfed. In conclusion, PACAP deficiency is accompanied by distinct 
changes in fecal microbiota composition with virtually absent bifidobacteria as a major hallmark that might be linked to increased 
susceptibility to disease.
Keywords: intestinal microbiota dynamics, pituitary adenylate cyclase activating polypeptide (PACAP), bifidobacteria, intestinal 
ecology, gut–brain axis, predisposition to immunopathology, probiotic immunomodulation
Introduction
Pituitary adenylate cyclase activating polypeptide 
( PACAP) was initially identifi ed as a neuropeptide in the 
hypothalamus stimulating adenylate cyclase activity in the 
pituitary gland [1]. Beyond the nervous system, PACAP 
is widely expressed in peripheral organs of the endocrine, 
respiratory, reproductive, and digestive system as well as 
in lymphoid organs including immune cells [2]. PACAP 
can bind to VPAC1, VPAC2, and PAC1 receptors that 
are present on innate immune cell subsets such as lym-
phocytes and macrophages, for instance [3–5]. In the con-
text of its virtual ubiquitous distribution, PACAP exerts 
a broad mode of biological actions with cytoprotective 
including anti-infl ammatory and anti-apoptotic properties 
in particular [5, 6]. Hence, PACAP-defi cient (PACAP−/−) 
mice display several morphological, biochemical, and be-
havioral abnormalities that are characterized by decreased 
fertility but higher mortalitity rates due to compromised 
respiratory and metabolic functions, in additon to hyper-
activity, decreased anxiety, depression-like behavior, and 
abnormal stress responses as reviewed by Reglodi and 
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colleagues [6]. PACAP−/− mice have been shown to be 
more vulnerable to harmful stimuli to the central nervous 
system, but also peripheral organs including peripheral 
nerves, kidney, and the intestinal tract [6]. For instance, 
applying the acute dextran sodium sulfate (DSS)-induced 
colitis model, PACAP−/− mice displayed 50% higher mor-
tality rates as compared to wildtype (WT) mice [7]. In ad-
dition, PACAP−/− mice were suffering from more severe 
chronic DSS-induced colitis, whereas 60% of diseased 
animals additionally developed colorectal tumors with 
aggressive phenotype [8]. Interestingly, naive PACAP−/− 
mice did not display histopathological changes in their 
intestinal mucosa. Hence, lack of endogeneous PACAP 
resulted in increased susceptibility of the murine host to 
intestinal infl ammation and infl ammation-induced colonic 
cancer development.
There is compelling evidence that the host microbiota 
constitutes a key factor in health and disease of verte-
brates. In fact, it has been shown that the gut microbiota 
is essentially involved in a multitude of physiological 
 processes including food digestion [9], fat metabolism 
[10], vitamin synthesis [11], intestinal angiogenesis [12], 
enteric nerve function [13], and protection from pathogens 
[14, 15] as well as immune cell development [16]. Con-
versely, pertubations of this complex intestinal ecosystem 
termed dysbiosis are associated with increased suscepti-
bility of the host to distinct intestinal (e.g., infl ammatory 
bowel disease, irritable bowel syndrome, coeliac disease) 
as well as to extra-intestinal immunopathological condi-
tions (e.g., multiple sclerosis, autism, depression, allergy, 
asthma, cardiovascular morbidities) [17]. Hence, the fi ne-
tuned orchestrated interplay between the intestinal com-
mensal microbiota and the host plays a pivotal role in im-
mune homeostasis, host cell physiology, and resistance to 
disease [17].
To date, however, no data are available regarding the 
intestinal microbiota composition of PACAP−/− mice. In 
the present study, we therefore addressed whether PACAP 
defi ciency was associated with qualitative and/or quantita-
tive differences in the gut microbiota repertoire that in turn 
may be linked to the phenotypes and increased susceptibil-
ity to immunopatholocal conditions observed in PACAP 
gene-defi cient mice. To accomplish this, we performed a 
comprehensive kinetic survey of the intestinal microbiota 
composition in PACAP−/− and corresponding WT mice 
starting 2 weeks postpartum until 18 months of age apply-
ing culture-independent molecular techniques.
Methods
Mice
PACAP gene-defi cient (PACAP−/−) mice and correspond-
ing WT counterparts were raised and maintained in open 
cages within an experimental semi-barrier (accessible only 
with laboratory coat, overshoes, caps, and sterile gloves) 
under standard conditions (22–24 °C room temperature, 
55 ± 15% humidity, 12 h light/12 dark cycle) in the ani-
mal facilities of the University of Pecs (Pecs, Hungary). 
Mice had unlimited access to autoclaved tap water and 
standard chow. Comparable numbers of male and female 
age-matched PACAP−/− and WT mice were included in 
the study at defi ned time points postpartum. Genotypes of 
mice were confi rmed by polymerase chain reaction (PCR) 
as described elsewhere [18].
Molecular analysis of fecal microbiota
Fresh fecal pellets were collected from corresponding 
mice at 2 weeks, 1 month, 3 months, 6 months, 12 months, 
and >15 months (i.e., between 15 and 18 months) of age, 
immediately snap-frozen in liquid nitrogen and stored at 
−80 °C until further processing. DNA was extracted from 
fecal samples as described previously [19, 20]. In brief, 
DNA was quantifi ed by using Quant-iT PicoGreen reagent 
(Invitrogen, UK) and adjusted to 1 ng/μl. Then, the main 
bacterial groups abundant in the murine intestinal micro-
biota including enterobacteria, enterococci, lactobacilli, 
bifi dobacteria, Bacteroides/Prevotella spp., Mouse Intes-
tinal Bacteroides, Clostridium coccoides group, and Clos-
tridium leptum group as well as total eubacterial loads 
were assessed by quantitative real-time PCR (qRT-PCR) 
with species-, genera-, or group-specifi c 16S rRNA gene 
primers (Tib MolBiol, Germany) as described previously 
[15, 21–23], and numbers of 16S rRNA gene copies per 
nanogram DNA of each sample were determined.
Statistical analysis
Medians and levels of signifi cance were determined by 
Mann–Whitney U test (GraphPad Prism v5, La Jolla, CA, 
USA) as indicated. Two-sided probability (p) values of 
≤0.05 were considered signifi cant.
Ethics statement
All animal experiments were conducted according to the 
European Guidelines for animal welfare (2010/63/EU) 
with approval of the commission for animal experiments 
(BA02/2000-15024/2011).
Results
Comprehensive culture-independent analysis of the fecal 
microbiota in PACAP−/− and WT mice over time
In order to provide a comprehensive kinetic survey of the 
main bacterial groups abundant in the intestinal tract of 
PACAP−/− and WT mice, we collected fecal samples of 
age- and sex-matched mice starting 2 weeks postpartum 
until the age of 18 months. Notably, due to limited num-
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bers in progressively aged and surviving mice lacking the 
PACAP gene, results derived from mice aged 15 to 18 
months of either genotype were pooled (indicated as >15 
months age group) and subjected to statistical analyses.
Total eubacterial gene numbers were highest in fecal 
samples derived from both PACAP−/− and WT mice at the 
beginning of the observation period as early as 2 weeks 
postpartum and higher as compared to any time points ana-
lyzed thereafter (i.e., >15 months; p < 0.001; Fig. 1). Fur-
thermore, irrespective of the genotype, total bacterial loads 
were lower in fecal samples taken from mice ≥6 months as 
compared to 1-month-old animals (p < 0.05–0.01; Fig. 1). 
By the age of ≥15 months, WT but not PACAP−/− mice dis-
played lower eubacterial gene numbers in their intestines 
as compared to corresponding mice ≤6 months of age (p < 
0.05–0.001; Fig. 1A). It is important to note, however, that 
the observed differences were rather minor (approximately 
0.5 order of magnitude).
When assessing gene numbers of commensal en-
terobacteria including Escherichia coli, 2-week-old and 
1-month-old WT mice harbored up to four orders of mag-
nitude more enterobacteria in their intestines as compared 
to WT mice aged ≥3 months (p < 0.001; Fig. 2A). In fact, 
fecal enterobacteria burdens were lower in mice of the 
oldest cohort as compared to any other time point (p < 
0.05–0.001; Fig. 2A). In 2-week-old PACAP−/− mice, fe-
Fig. 1. Total eubacterial gene numbers in fecal samples derived 
from PACAP-deficient and wildtype mice over time. Individual 
intestinal total eubacterial loads were quantitatively assessed in 
fecal samples derived from (A) wildtype (WT, closed circles) and 
(B) pituitary adenylate cyclase activating polypeptide-deficient 
(PACAP−/−, open circles) mice at defined time points postpartum 
(as indicated on the x axis; wk: weeks; mo: months) by qRT-
PCR and expressed as 16S rRNA gene numbers per nanogram 
DNA. Medians, numbers of analyzed animals (in parentheses), 
and significance levels (p values) determined by Mann–Whitney 
U test are indicated
Fig. 2. Fecal gene numbers of enterobacteria in PACAP-
deficient and wildtype mice over time. Individual intestinal 
loads of enterobacteria were quantitatively assessed in fecal 
samples derived from (A) wildtype (WT, closed circles) and 
(B) pituitary adenylate cyclase activating polypeptide-deficient 
(PACAP−/−, open circles) mice at defined time points postpartum 
(as indicated on the x axis; wk: weeks; mo: months) by qRT-
PCR and expressed as 16S rRNA gene numbers per nanogram 
DNA. Medians, numbers of analyzed animals (in parentheses), 
and significance levels (p values) determined by Mann–Whitney 
U test are indicated
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cal enterobacteria loads were higher as compared to ani-
mals aged ≥3 months (p < 0.001; Fig. 2B). Furthermore, 
 PACAP−/− mice over 12 months of age exhibited less en-
terobacteria in their feces than 1-month-old and 3-month-
old animals (p < 0.001; Fig. 2B). The overall decrease in 
fecal enterobacteria burdens observed during the entire 
survey period was approximately 2.5 orders of magnitude 
in PACAP−/− animals (Fig. 2B).
In mice of either genotype, not only fecal enterococci 
gene numbers were rather low but also kinetic changes 
were minor. Three-month-old WT mice displayed 1.0–1.5 
orders of magnitude lower enterococci burdens as com-
pared to younger counterparts (p < 0.005; Fig. 3A). In 
≤1-month-old PACAP−/− mice, enterococci gene numbers 
were higher than those detected in feces of ≥3-month-old 
animals (p < 0.005; Fig. 3B). Notably, enterococci loads in 
gene-defi cient mice older than 3 months were close to the 
detection limit (Fig. 3B).
Irrespective of the genotype, intestinal lactobacilli 
loads were approximately two orders of magnitude higher 
in ≤3-month-old mice than in older counterparts (p < 0.05–
0.001; Fig. 4). In addition, WT mice in the youngest cohort 
displayed slightly higher fecal burdens of lactobacilli as 
compared to 1-month-old animals (p < 0.001; Fig. 4A).
Two-week-old WT mice harbored higher bifi dobacte-
ria gene numbers in their feces as compared to younger 
(except for 3-month-old) mice (p < 0.001; Fig. 5A). Even 
though 6-month-old WT animals exhibited very low intes-
Fig. 3. Fecal gene numbers of enterococci in PACAP-deficient 
and wildtype mice over time. Individual intestinal loads of 
enterococci were quantitatively assessed in fecal samples derived 
from (A) wildtype (WT, closed circles) and (B) pituitary adenylate 
cyclase activating polypeptide-deficient (PACAP−/−, open circles) 
mice at defined time points postpartum (as indicated on the 
x axis; wk: weeks; mo: months) by qRT-PCR and expressed as 
16S rRNA gene numbers per nanogram DNA. Medians, numbers 
of analyzed animals (in parentheses), and significance levels 
(p values) determined by Mann–Whitney U test are indicated
Fig. 4. Fecal gene numbers of lactobacilli in PACAP-deficient and 
wildtype mice over time. Individual intestinal loads of lactobacilli 
were quantitatively assessed in fecal samples derived from (A) 
wildtype (WT, closed circles) and (B) pituitary adenylate cyclase 
activating polypeptide-deficient (PACAP−/−, open circles) mice 
at defined time points postpartum (as indicated on the x axis; 
wk: weeks; mo: months) by qRT-PCR and expressed as 16S 
rRNA gene numbers per nanogram DNA. Medians, numbers 
of analyzed animals (in parentheses), and significance levels 
(p values) determined by Mann–Whitney U test are indicated
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tinal bifi dobacteria numbers in their intestines, the fecal 
loads further declined to the detection limit thereafter (p < 
0.05–0.01; Fig. 5A). Remarkably, even in the youngest co-
hort, bifi dobacteria were (if at all) abundant only in very 
low numbers (i.e., close to the detection limit) in the intes-
tinal tract of PACAP−/− mice (Fig. 5B).
When analyzing obligate anaerobic gram-negative 
commensals, fecal loads of Bacteroides/Prevotella spp. 
were highest in the youngest and lowest in the oldest co-
hort of WT mice (p < 0.05–0.001; Fig. 6A). In PACAP−/− 
mice, however, fecal gene numbers of Bacteroides/Pre-
votella spp. slightly decreased until 3 months of age (p < 
0.001) but were higher thereafter (p < 0.05–0.005) and 
comparable to loads observed in the youngest cohort 
(Fig. 6B).
In both PACAP−/− and WT mice, mouse intestinal 
Bacteroides were up to 1.5 orders of magnitude higher in 
the fecal samples derived from animals aged ≥3 months 
as compared to 2-week-old and 1-month-old counter-
parts (p < 0.05–0.001; Fig. 7). Conversely, fecal gene 
numbers of Clostridium coccoides were slightly lower in 
>15-month-old as compared to ≤3-month-old WT mice 
(p < 0.05–0.005; Fig. 8A). In >6-month-old PACAP−/− 
mice, C. coccoides loads were up to 1.5 orders lower in 
the feces as compared to those detected in younger ani-
mals (p < 0.05–0.001; Fig. 8B).  Fecal gene numbers of 
the C. leptum group increased after 2 weeks of age in 
WT animals by approximately one order of magnitude 
and remained stable until the end of the  observation pe-
Fig. 5. Fecal gene numbers of bifidobacteria in PACAP-
deficient and wildtype mice over time. Individual intestinal 
loads of bifidobacteria were quantitatively assessed in fecal 
samples derived from (A) wildtype (WT, closed circles) and 
(B) pituitary adenylate cyclase activating polypeptide-deficient 
(PACAP−/−, open circles) mice at defined time points postpartum 
(as indicated on the x axis; wk: weeks; mo: months) by qRT-
PCR and expressed as 16S rRNA gene numbers per nanogram 
DNA. Medians, numbers of analyzed animals (in parentheses), 
and significance levels (p values) determined by Mann–Whitney 
U test are indicated
Fig. 6. Fecal gene numbers of Bacteroides/Prevotella spp. 
in PACAP-deficient and wildtype mice over time. Individual 
intestinal loads of Bacteroides/Prevotella spp. were quantitatively 
assessed in fecal samples derived from (A) wildtype (WT, 
closed circles) and (B) pituitary adenylate cyclase activating 
polypeptide-deficient (PACAP−/−, open circles) mice at defined 
time points postpartum (as indicated on the x axis; wk: weeks; 
mo: months) by qRT-PCR and expressed as 16S rRNA gene 
numbers per nanogram DNA. Medians, numbers of analyzed 
animals (in parentheses), and significance levels (p values) 
determined by Mann–Whitney U test are indicated
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riod (p < 0.05–0.001; Fig. 9A). Interestingly, intestinal 
C. leptum loads were virtually comparable over time in 
PACAP−/− mice (n.s.; Fig. 9B).
Genotype-dependent differences in fecal microbiota
of PACAP−/− and WT mice at defined time points
postpartum
When comparing total eubacterial gene numbers in fecal 
samples derived from WT and PACAP−/− mice at defi ned 
time points postpartum, no differences could be observed 
(n.s.; Fig. 10). Fecal enterobacteria loads, however, were 
two orders of magnitude lower in 1 month old PACAP−/− 
as compared to age-matched WT mice (p < 0.001; Fig. 11A), 
whereas, conversely, respective loads were slightly higher 
in the former versus the latter when older than 15 months 
(p < 0.05; Fig. 11A). PACAP−/− mice harbored more entero-
cocci in their intestines as compared to WT counterparts, 
whereas the opposite was true for ≥6-month-old mice 
(p < 0.001; Fig. 11B). Whereas lactobacilli were higher in 
fecal samples derived from  PACAP−/− as compared to WT 
mice of the respective oldest cohorts (i.e., >15 months of 
age, p < 0.005; Fig. 12A), intestinal bifi dobacteria were 
virtually absent in PACAP−/− mice and up to two orders 
of magnitude lower until the age of 6 months (p < 0.001; 
Fig. 12B). Obligate anaerobic gram-negative commensals 
such as Bacteroides/Prevotella spp. were up to 1.5 order 
of magnitude higher in ≥12-month-old PACAP−/− as com-
pared to age-matched WT control animals (p < 0.05–0.001; 
Fig. 7. Fecal gene numbers of Mouse Intestinal Bacteroides in 
PACAP-deficient and wildtype mice over time. Individual intes-
tinal loads of Mouse Intestinal Bacteroides were quantitatively 
assessed in fecal samples derived from (A) wildtype (WT, closed 
circles) and (B) pituitary adenylate cyclase activating polypep-
tide-deficient (PACAP−/−, open circles) mice at defined time 
points postpartum (as indicated on the x axis; wk: weeks; mo: 
months) by qRT-PCR and expressed as 16S rRNA gene num-
bers per nanogram DNA. Medians, numbers of analyzed animals 
(in parentheses), and significance levels (p values) determined 
by Mann–Whitney U test are indicated
Fig. 8. Fecal gene numbers of Clostridium coccoides in PACAP-
deficient and wildtype mice over time. Individual intestinal loads 
of Clostridium coccoides were quantitatively assessed in fecal 
samples derived from (A) wildtype (WT, closed circles) and 
(B) pituitary adenylate cyclase activating polypeptide-deficient 
(PACAP−/−, open circles) mice at defined time points postpartum 
(as indicated on the x axis; wk: weeks; mo: months) by qRT-
PCR and expressed as 16S rRNA gene numbers per nanogram 
DNA. Medians, numbers of analyzed animals (in parentheses), 
and significance levels (p values) determined by Mann–Whitney 
U test are indicated
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Fig. 13A), which also held true for Mouse Intestinal Bac-
teroides in respective 1-month-old and 6-month-old mice 
(p < 0.05; Fig. 13B). Interestingly, fecal loads of obligate 
gram-positive species such as C. coccoides and C. leptum 
groups did not differ in PACAP−/− and WT mice at either 
time point postpartum (n.s.; Fig. 14). 
Discussion
During the past years, the commensal microbiota has 
gained increasing attention concerning their impact in 
health and disease [24]. Microbial colonization and host 
immune development and maturation run in parallel and 
are essentially involved in regulation of intestinal (patho)
physiology in mice and men [25, 26]. Given the pivotal 
interactions between the intestinal microbiota and host 
physiology, pertubations of this fi ne-tuned, orchestrated 
interplay result in increased vulnerability of the host to 
external (harmful) stimuli and increased susceptibility to 
disease not only of the intestinal tract [17, 27], in fact, 
phenomena that are shared by PACAP gene-defi cient mice 
[6]. This prompted us to present a comprehensive kinetic 
survey of the intestinal microbiota composition and their 
changes “during lifetime” of PACAP−/− and corresponding 
WT mice for the fi rst time.
The microbial colonization of the intestinal tract starts 
immediately after birth with facultative anaerobic com-
mensal species such as enterobacteria, enterococci, and 
lactobacilli as the fi rst colonizers [28], as we could con-
fi rm with highest respective fecal loads in the youngest 
murine cohort (i.e., 2 weeks postpartum) in our study. Irre-
spective of the genotype, fecal gene numbers of respective 
commensals declined with progressive aging, particularly 
after 3 months of age. Conversely, obligate anaerobic bac-
terial species including Bacteroides and Clostridium spe-
cies, but also bifi dobacteria, usually establish gradually in 
Fig. 9. Fecal gene numbers of Clostridium leptum in PACAP-
deficient and wildtype mice over time. Individual intestinal loads of 
Clostridium leptum were quantitatively assessed in fecal samples 
derived from (A) wildtype (WT, closed circles) and (B) pituitary 
adenylate cyclase activating polypeptide-deficient (PACAP−/−, open 
circles) mice at defined time points postpartum (as indicated on the 
x axis; wk: weeks; mo: months) by qRT-PCR and expressed as 16S 
rRNA gene numbers per nanogram DNA. Medians, numbers of 
analyzed animals (in parentheses) and significance levels (p values), 
determined by Mann–Whitney U test are indicated
Fig. 10. Fecal total eubacterial gene numbers in PACAP-deficient as compared to wildtype mice over time. Individual intestinal total 
eubacterial loads were quantitatively assessed in fecal samples derived from wildtype (WT, closed circles) and pituitary adenylate 
cyclase activating polypeptide-deficient (PACAP−/−, open circles) mice at defined time points postpartum (as indicated on the x axis; 
wk: weeks; mo: months) by qRT-PCR and expressed as 16S rRNA gene numbers per nanogram DNA. Medians and numbers of 
analyzed animals (in parentheses) are indicated
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mice and men [29, 30]. Our results are well in line, given 
that Mouse Intestinal Bacteroides increased in either mice 
after 1 month of age, for instance, whereas Bacteroides/
Prevotella spp. were lowest in feces of >15-month-old WT 
but not PACAP−/− mice. Strikingly, bifi dobacteria were 
virtually absent in the intestinal tract of PACAP−/− mice, 
even in still breastfed 2-week-old infants. In WT mice, 
however, bifi dobacterial loads were highest in 2-week-old 
mice and subsequently declined after 3 months of age.
Bifi dobacteria belong to the phylum Actinobacteria 
and constitute the predominant microbial group in healthy 
breastfed babies. It remains relatively stable during adult-
hood and tend to decrease upon senescence [28]. Whereas 
bifi dobacteria are considered important for intestinal ho-
meostasis, a delayed bifi dobacterial colonization of the 
intestinal tract during infancy results in increased suscep-
tibility to diseases in childhood and later in life [31]. For 
instance, dysbiosis with decreased bifi dobacterial numbers 
have been associated with distinct immunopathologies 
such as infl ammatory bowel disease, irritable bowel dis-
ease, celiac disease, and atopic disease [28]. In our own 
studies, conventionally colonized mice gene-defi cient for 
nucleotide-binding oligomerization domain (NOD) 2 or 
Toll-like receptor (TLR) 9 were virtually deprived from 
intestinal bifi dobacteria but suffered from more distinct 
Toxoplasma gondii-induced infl ammatory sequelae in in-
testinal and extra-intestinal compartments including the 
brain [20, 32].
Genome-based analyses revealed a number of factors 
that might explain host-benefi cial mechanisms exerted by 
bifi dobacteria as reviewed by Klijn et al. [33]: production 
of 1) bacteriocins, further of 2) lactic acid and 3) acetic 
acid, thereby lowering the intraluminal pH, 4) exerting 
functional oxidative stress response mechanisms, and thus 
Fig. 11. Fecal gene numbers of enterobacteria and enterococci in PACAP-deficient as compared to wildtype mice over time. Individual 
loads of (A) enterobacteria and (B) enterococci were quantitatively assessed in fecal samples derived from wildtype (WT, closed circles) 
and pituitary adenylate cyclase activating polypeptide-deficient (PACAP−/−, open circles) mice at defined time points postpartum (as 
indicated on the x axis; wk: weeks; mo: months) by qRT-PCR and expressed as 16S rRNA gene numbers per nanogram DNA. Medians, 
numbers of analyzed animals (in parentheses), and significance levels (p values) determined by Mann–Whitney U test are indicated
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supporting the host phalanx angainst invading (entero)
pathogens as well as providing metabolic features such 
as 5) production of vitamins, 6) hydrolysis of bile salts, 
7) production of conjugated linoleic acid, and 8) degrada-
tion of oxalate. 9) Importantly, a very recent report pro-
vided a direct link between bifi dobacteria and neuromodu-
latory activities, given that a particular Bifi dobacterium 
dentium strain was able to modulate visceral sensitivity in 
the intestinal tract by production of γ-aminobutyric acid 
(GABA), the primary inhibitory neurotransmitter in the 
central nervous system of mammals [34]. This report to-
gether with our study further underlines the (patho)physi-
ological importance of the gut–brain axis.
Given their health-promoting features, viable bifi do-
bacterial strains have been introduced into probiotic for-
mulations such as VSL#3 and have been shown effi cient 
in ameliorating symptoms and maintaining remission of 
patients suffering from infl ammatory bowel disease [28]. 
Very recently, we were able to demonstrate the extensive 
impact of VSL#3 treatment on mucosal, peripheral, and 
systemic innate and adaptive immunity exerting benefi cial 
anti-infl ammatory effects in intestinal as well as systemic 
compartments of mice that had been subjected to broad-
spectrum antibiotic treatment [27]. In addition, VSL#3 
treatment was suffi cient to attenuate intestinal, but also 
extra-intestinal including systemic pro-infl ammatory re-
sponses upon murine infection with the enteropathogen 
Campylobacter jejuni [35].
It is, hence, highly likely that the lack of intestinal bi-
fi dobacteria observed in PACAP−/− mice might be one key 
factor explaining their vulnerability to cell-toxic stimuli 
and increased susceptibility to immunopathological condi-
tions in both intestinal and extra-intestinal compartments.
In addition, we were able to show that facultative an-
aerobic commensals such as enterobacteria (e.g., E. coli) 
were lower in the intestines of 1-month-old PACAP−/− as 
Fig. 12. Fecal gene numbers of lactobacilli and bifidobacteria in PACAP-deficient as compared to wildtype mice over time. Individual 
loads of (A) lactobacilli and (B) bifidobacteria were quantitatively assessed in fecal samples derived from wildtype (WT, closed circles) 
and pituitary adenylate cyclase activating polypeptide-deficient (PACAP−/−, open circles) mice at defined time points postpartum (as 
indicated on the x axis; wk: weeks; mo: months) by qRT-PCR and expressed as 16S rRNA gene numbers per nanogram DNA. Medians, 
numbers of analyzed animals (in parentheses), and significance levels (p values) determined by Mann–Whitney U test are indicated
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compared to WT mice, which also held true for enterococci 
later in murine life (i.e., ≥6 months of age). Whereas gene 
numbers of obligate anaerobic gram-negative commensals 
such as Mouse Intestinal Bacteroides were slightly higher 
in the feces of PACAP−/− versus WT mice aged 1 and 6 
months, this held true for Bacteroides/Prevotella spp. in 
the intestines later in life (i.e., ≥12 months of age).
Conclusion
We conclude that the described genotype-dependent dif-
ferences in gut microbiota composition and their develop-
ment over time with the virtually absent intestinal bifi do-
bacteria as hallmark might explain the distinct phenotypes 
observed in PACAP−/− mice upon cell-toxic (i.e., oxidative, 
traumatic, infl ammatory) challenges further supporting the 
major (patho)physiological impact of the gut–brain axis.
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